Lee Robert Johnston

Ascension Orthopedics, Inc. designs, develops and markets orthopedic implants and devices. The company was founded by Jerome J. Klawitter in 1996 and is headquartered in Overland Park, KS.

Tutogen Medical, Inc. manufactures sterile biological implant products made from human and animal tissue. Tutogen utilizes its Tutoplast Process® of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology and general surgery procedures. The Company''s Tutoplast® products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc. the Mentor Corporation, IOP, Inc. and through independent distributors and subsidiaries in the U.S. and other international markets. Tutogen Medical is located in West Paterson, NJ.

Power Medical Interventions, Inc. develops and markets surgical instruments for bariatric, cardiothoracic, colorectal and general surgical applications. PMI's micro-robotic, computer-assisted SurgASSIST system is used to cut tissue, close wounds and reconnect anatomical structures. The Company was founded in 1999 by Michael P. Whitman and is headquarters in Langhorne, PA.

Cellomics, Inc. provides imaging technology products and services. It is a provider of technologies and products for the advancement of cell science research, including complete systems for high-content imaging of cells, tissues and whole organisms. The firm's platform includes automated imaging instruments, image analysis software, data management and bioinformatics software, coupled with reagents, cell-culture media, sera and specialty media formulations, along with laboratory automation and services. The company's offering is aimed at providing life science researchers with a quantitative, automated approach to understanding the biology of cells, including stem cells and cell systems, supporting all aspects of the drug discovery process as well as academic and systems biology research. Cellomics was founded on October 1996 and is headquartered in Pittsburgh, PA.

Oncormed, Inc., is a genomics services company that characterizes newly discovered genes to establish their medical relevance and provides molecular profiling of patients for pharmacogenomic and therapeutic purposes. The company's mission is to accelerate the translation of cancer related genetic discoveries into clinically useful products and services through strategic collaborations with pharmaceutical, genomic and biotechnology companies.